A potent serotonin-modulating compound AP-267 attenuates morphine withdrawal-induced blood-brain barrier dysfunction in rats

Annals of the New York Academy of Sciences

Volumn 1074, Issue , 2006, Pages 482-496

  Sharma, Hari S ^a,b   Lundstedt, Torbjörn ^c,d   Boman, Arne ^c   Lek, Per ^c   Seifert, Elisabeth ^c   Wiklund, Lars ^b   Ali, Syed F ^a  

^a National Center for Toxicology Research   (United States)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c AcurePharma AB   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

5 HT2c receptor; AP 267; Blood brain barrier; Dependence; Evans blue; Morphine; Radioiodine; Serotonin; Spontaneous withdrawal; Withdrawal symptoms

Indexed keywords

AP 267; EVANS BLUE; MORPHINE; RADIOACTIVE IODINE; SEROTONIN AGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD BRAIN BARRIER; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG POTENCY; MALE; MEMBRANE PERMEABILITY; MORPHINE ADDICTION; NONHUMAN; RAT; STRESS; WITHDRAWAL SYNDROME;

EID: 33749541449     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1369.049     Document Type: Conference Paper

References (63)

1. SHARMA, H.S. & J. WESTMAN. 2004. The Blood-Spinal Cord and Brain Barriers in Health and Disease. Academic Press. San Diego, CA.
2. SHARMA, H.S. 2004. Blood-brain and spinal cord barriers in stress. In The Blood-Spinal Cord and Brain Barriers in Health and Disease. H.S. Sharma & J. Westman, Eds.: 231-298. Elsevier Academic Press. San Diego, CA.
3. SHARMA, H.S., R. PATNAIK, A.K. RAY & P.K. DEY. 2004. Blood-central nervous system barriers in morphine dependence and withdrawal. In The Blood-Spinal Cord and Brain Barriers in Health and Disease. H.S. Sharma & J. Westman, Eds.: 299-328. Elsevier Academic Press. San Diego, CA.
4. SHARMA, H.S. & S.F. ALI. 2006. Alterations in blood-brain barrier function by morphine and methamphetamine. Ann. N. Y. Acad. Sci. (in this volume).
5. SHARMA, H.S. 2004. Influence of serotonin on the blood-brain and blood-spinal cord barriers. In The Blood-Spinal Cord and Brain Barriers in Health and Disease. H.S. Sharma & J. Westman, Eds.: 117-158. Elsevier Academic Press, San Diego, CA.
6. GUAN, X.M. & W.J. MCBRIDE. 1989. Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release. Brain Res. Bull. 23: 541-547.
7. KILPATRICK, G.J., B.J. JONES & M.B. TYERS. 1987. Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature 330: 746-748.
8. BARNES, J.M., N.M. BARNES, S. CHAMPANERIA, et al. 1990. Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat. Neuropharmacology 29: 1037-1045.
9. PERRY, D.C. 1990. Autoradiography of [3H]quipazine in rodent brain. Eur. J. Pharmacol. 187: 75-85.
10. MENGOD, G., M. POMPEIANO, M.I. MARTINEZ-MIR & J.M. PALACIOS. 1990. Localisation of the mRNA for the 5-HT2 receptor by in situ hybridisation histochemistry. Correlation with the distribution of receptor sites. Brain Res. 524: 139-143.
11. CURZON, G. & G.A. KENNETT. 1990. m-CPP: a tool for studying behavioural responses associated with 5-HT(1C) receptors. Trends Pharmacol. Sci. 11: 181-182.
12. YAGALOFF, K.A. & P.R. HARTIG. 1985. 125I-lysergic acid diethylamide binds to a novel serotonergic site on rat choroid plexus epithelial cells. J. Neurosci. 5: 3178-3183.
13. PAZOS, A., D. HOYER & J.M. PALACIOS. 1984. The binding of serotonergic ligands to the porcine choroid plexus: characterisation of a new type of serotonin recognition site. Eur. J. Pharmacol. 196: 539-546.
14. RAY, A.K. & P.K. DEY. 1980. Morphine analgesia following its infusion into different liquor spaces in rat brain. Arch. Int. Pharmacodyn. Ther. 246: 108-117.
15. GIANUTSOS, G., M.D. HYNES, R.B. DRAWBAUGH & H. LAL. 1975a. Paradoxical absence of aggression during naloxone-precipitated morphine withdrawal. Psychopharmacologia 43: 43-46.
16. GIANUTSOS, G., M.D. HYNES, R.B. DRAWBAUGH & H. LAL. 1975b. The narcotic withdrawal syndrome in rats. In Methods in Narcotic Research. S. Ehrenpreis & A. Neidle, Eds.: 293-309. Marcel Dekker Inc. New York, NY.
17. SHARMA, H.S. 1987. Effect of captopril (a converting enzyme inhibitor) on blood-brain barrier permeability and cerebral blood flow in normotensive rats. Neuropharmacology 26: 85-92.
18. SHARMA, H.S. & J. CERVÓS-NAVARRO. 1990. Nimodipine improves cerebral blood flow and reduces brain edema, cellular damage and blood-brain barrier permeability following heat stress in young rats. In Pharmacology of Cerebral Ischemia 1990. J. Krieglstein & H. Oberpichler, Eds.: 303-310. CRC Press. Boca Raton, FL.
19. SHARMA, H.S. & P.K. DEY. 1986. Influence of long-term immobilization stress on regional blood-brain barrier permeability, cerebral blood flow and 5-HT level in conscious normotensive young rats. J. Neurol. Sci. 72: 61-76.
20. SHARMA, H.S. & P.K. DEY. 1987. Influence of long-term acute heat exposure on regional blood-brain barrier permeability, cerebral blood flow and 5-HT level in conscious normotensive young rats. Brain Res. 424: 153-162.
21. SHARMA, H.S., J. CERVÓS-NAVARRO & P.K. DEY. 1991. Increased blood-brain barrier permeability following acute short-term forced-swimming exercise in conscious normotensive young rats. Neurosci. Res. 10: 211-221.
22. SHARMA, H.S., J. WESTMAN, J. CERVÓS-NAVARRO, et al. 1995. Probable involvement of serotonin in the increased permeability of the blood-brain barrier by forced swimming. An experimental study using Evans blue and 1311-sodium tracers in the rat. Behav. Brain Res. 72: 189-196.
23. SHARMA, H.S. 2005. Selective neuronal vulnerability and heat shock protein expression in stress Invited Review. In Recent Modalities of Brain Research with Special Reference to Depression and Dementia. S. N. Sarbadhikari, Ed.: 97-152. Nova Science Publishers, Inc. NY.
24. SHARMA, H.S. 1999. Pathophysiology of blood-brain barrier, brain edema and cell injury following hyperthermia: new role of heat shock protein, nitric oxide and carbon monoxide. An experimental study in the rat using light and electron microscopy. Acta Universitatis Upsaliensis 830: 1-94.
25. SHARMA, H.S., P.K. DEY & Y. OLSSON. 1989. Brain edema, blood-brain barrier permeability and cerebral blood flow changes following intracarotid infusion of serotonin: modification with cyproheptadine and indomethacin. In Pharmacology of Cerebral Ischemia 1988. J. Krieglstein Ed.: 317-323. CRC Press. Boca Raton, FL.
26. SHARMA, H.S., Y. OLSSON & P.K. DEY. 1990. Blood-brain barrier permeability and cerebral blood flow following elevation of circulating serotonin level in the anaesthetized rats. Brain Res. 517: 215-223.
27. SHARMA, H.S. 2004. Pathophysiology of the blood-spinal cord barrier in traumatic injury. In The Blood-Spinal Cord and Brain Barriers in Health and Disease. H.S. Sharma & J. Westman Eds.: 437-518. Elsevier Academic Press, San Diego, CA.
28. SHARMA, H.S. 2003. Neurotrophic factors attenuate microvascular permeability disturbances and axonal injury following trauma to the rat spinal cord. Acta Neurochir. Suppl. 86: 383-388.
29. SHARMA, H.S. 2005. Neuroprotective effects of neurotrophins and melanocortins in spinal cord injury: an experimental study in the rat using pharmacological and morphological approaches. Ann. N. Y. Acad. Sci. 1053: 407-421.
30. SHARMA, H.S. 2005. Pathophysiology of blood-spinal cord barrier in traumatic injury and repair. Curr. Pharm. Des. 11: 1353-1389.
31. SHARMA, H.S., Y. OLSSON & P.K. DEY. 1990. Early accumulation of serotonin in rat spinal cord subjected to traumatic injury. Relation to edema and blood flow changes. Neuroscience 36: 725-730.
32. SHARMA, H.S., P.J. HOOPES. 2003. Hyperthermia induced pathophysiology of the central nervous system. Int. J. Hypertherm. 19: 325-354.
33. AZMITIA, E.C., R.B. MURPHY & P.M. WHITAKER-AZMITIA. 1990. NDMA (ecstasy) effects on cultured serotonergic neurons: evidence for Ca2(+)-dependent toxicity linked to release. Brain Res. 510: 97-103.
34. ANANTH, U.S., U. LETTI. 1987. Stimulation of phosphoinositide hydrolysis by serotonin in C6 glioma cells. J. Neurochem. 48: 253-261.
35. LUCAITES, V.L., D.L. NELSON, D.B. WAINSCOTT & M. BAEZ. 1996. Receptor subtype and density determine the coupling repertoire of the 5-HT2 receptor subfamily. Life Sci. 59: 1081-1095.
36. AZMITIA, E.C. 2001. Modern views on ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis. Brain Res. Bull. 56: 413-424.
37. BARNES, N.M., C.H. CHENG, B. COSTALL, et al. 1992. Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride. Br. J. Pharmacol. 107: 233-239.
38. BLAUW, G.J., P. VAN BRUMMELEN & P.A. VAN ZWIETEN. 1988. Serotonin induced vasodilatation in the human forearm is antagonized by the selective 5-HT3 receptor antagonist ICS 205-930. Life Sci. 43: 1441-1449.
39. HOYER, D., D.E. CLARKE, J.R. FOZARD, et al. 1994. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46: 157-203.
40. CARBONI, E., E. ACQUAS, P. LEONE, et al. 1988. 5-HT3 receptor antagonists block morphine- and nicotine-induced place-preference conditioning. Eur. J. Pharmacol. 151: 159-160.
41. HIGGINS, G.A., N. JOHARCHI, P. NGUYEN & E.M. SELLERS. 1992. Effect of the 5-HT3 receptor antagonists, MDL72222 and ondansetron on morphine place conditioning. Psychopharmacology (Berl.) 106: 315-320.
42. ROYCHOUDHURY, M. & S.K. KULKARNI. 1986. Prevention of morphine discontinuation phenomenon in mice by ondansetron, a selective 5-HT3 antagonist. Methods Find Exp. Clin. Pharmacol. 18: 677-683.
43. HUI, S.C., E.L. SEVILLA & C.W. OGLE. 1993. 5-HT3 antagonists reduce morphine self-administration in rats. Br. J. Pharmacol. 110: 1341-1346.
44. WAHL, M., A. UNTERBERG, A. BAETHMANN & L. SCHILLING. 1988. Mediators of blood-brain barrier dysfunction and formation of vasogenic brain edema. J. Cereb. Blood Flow Metab. 8: 621-634.
45. WESTERGAARD, E. 1975a. Enhanced vesicular transport of exogenous peroxidase across cerebral vessels, induced by serotonin. Acta Neuropathol. (Berl.) 32: 27-42.
46. WESTERGAARD, E. 1977. The blood-brain barrier to horseradish peroxidase under normal and experimental conditions. Acta Neuropathol. 39: 181-188.
47. WESTERGAARD, E. 1980. Ultrastructural properties of cerebral microvasculature under normal and experimental conditions after application of tracers. Adv. Neurol. 28: 55-74.
48. WINKLER, T., H.S. SHARMA, E. STÅLBERG, et al. 1995. Impairment of blood-brain barrier function by serotonin induces desynchronisation of spontaneous cerebral cortical activity. Experimental observations in the anaesthetised rat. Neuroscience 68: 1097-1104.
49. AUER, L.M., K. LEBER & I. SAYAMA. 1985. Effect of serotonin and its antagonist ketanserin on pial vessels. J. Cereb. Blood Flow Metab. 5: 517-525.
50. EDVINSSON, L. & E.T. MACKENZIE. 1977. Amine mechanisms in the cerebral circulation. Pharmacol. Rev. 28: 275-348.
51. SHARMA, H.S., J. WESTMAN & F. NYBERG. 1998. Pathophysiology of brain edema and cell changes following hyperthermic brain injury. In Brain Functions in Hot Environment, Vol. 115. H.S. Sharma & J. Westman Eds.: 351-412. Progress in Brain Research. Elsevier, North Holland, B. V. Amsterdam.
52. GERZER, R., A.R. BRASH & J.G. HARDMAN. 1986. Activation of soluble guanylate cyclase by arachidonic acid and 15-lipoxygenase products. Biochim. Biophys. Acta. 29;886: 383-389.
53. HAUBRICH, D.R., J. PEREZ-CRUET & W.D. REID. 1973. Prostaglandin E1 causes sedation and increases 5-HT turnover in rat brain. Br. J. Pharmacol. 48: 80-87.
54. DAWSON, V.L., V.M. KIZUSHI, P.L. HUANG, et al. 1996. Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J. Neurosci. 16: 2479-2487.
55. BACA, G.M. & G.C. PALMER. 1978. Presence of hormonally-sensitive adenylate cyclase receptors in capillary-enriched fractions from rat cerebral cortex. Blood Vessels 15: 286-296.
56. GULLIS, R.J., C.E. ROWE. 1975. The stimulation by transmitter substances and putative transmitter substances of the net activity of phospholipase A2 of synaptic membrane of cortex of guinea-pig brain. Biochem. J. 148: 197-198.
57. HUANG, M. & O.P. ROSTAD. 1983. Effects of vasoactive intestinal polypeptide, monoamines, prostaglandins and 2-chloroadenosine on adenylate cyclase in rat cerebral microvessels. J. Neurochem. 40: 719-726.
58. JOÓ, F. 1985. The blood-brain barrier in vitro: ten years of research on microvessels isolated from the brain. Neurochem. Int. 7: 1-25.
59. JOÓ, F., P. TEMESVÁRI & E. DUX. 1983. Regulation of the macromolecular transport in the brain microvessels: the role of cyclic GMP. Brain Res. 278: 165-174.
60. KARNUSHINA, I., I. TOTH, E. DUX & F. JOÓ. 1980. Presence of the guanylate cyclase in brain capillaries: histochemical and biochemical evidences. Brain Res. 189: 588-592.
61. PALMER, G.C. 1983. Biochemical mechanisms of the microvasculature. Physiol. Pharmacol. Microcirc. 1: 1-37.
62. MANYHAN, W.G. 1999. VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase/cGMP-dependent pathway. Am. J. Physiol. 276: C1148-C1153.
63. SHARMA, H.S., P. ALM & WESTMAN. 1998. Nitric oxide and carbon monoxide in the pathophysiology of brain functions in heat stress. In Brain Functions in Hot Environment, Vol. 115. H.S. Sharma & J. Westman Eds.: 297-333. Progress in Brain Research. Elsevier, North Holland, P. V. Amsterdam.